ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research   
  • J Mol Pharm Org Process Res 2017, Vol 5(1): 137
  • DOI: 10.4172/2329-9053.1000137

Brain Targeting Potential of Intravenous Carbamazepine SNEDDS

Gannu Praveen Kumar1*, Rambhau D2 and Apte SS3
1University College of Pharmaceutical Sciences, Kakatiya University, Warangal, India
2Center for Nanotechnology, Pulse Advanced Research Center, , Hyderabad, India
3NDDS Unit, Natco Research Center, , Hyderabad, India
*Corresponding Author : Gannu Praveen Kumar, Professor & Principal, Department of Pharmaceutics, Sahasra Institute of Pharmaceutical Sciences, Warangal, India, Tel: +91-9397398024, Email: ghalo2010@gmail.com

Received Date: Sep 20, 2017 / Accepted Date: Oct 04, 2017 / Published Date: Oct 09, 2017

Abstract

Purpose: The objective of this study was to evaluate the ability of nano-droplets of Self Nano Emulsifying Drug Delivery System to diffuse into the brain tissue.

Methods: The preconcentrate was prepared by dissolving oils, surfactants and cosolvents in 1:1 mixture of methanol and chloroform and flash evaporated at 50°C and was stored at room temperature until their use in subsequent studies. CSEDD with surfactant polysorbate-80 were radiolabel led with radioactive C18 triglyceride. The nanodroplets formed by CSEDD in 5% dextrose were subjected to evaluation in blood and brain.

Results: The intravenous pharmacokinetics of carbamazepine in rats of CSEDD formulation generated high initial serum levels (5.25 mcg/ml) at 0.25 h when compared to C-Sol (3.91 mcg/ml) at 0.5 h. It was found that oil to surfactant ratio had an impact on the physical characteristics of the nano-emulsion formed. The brain levels of CBZ from optimized CSEDD were significantly high at all-time points when compared to plain solution. The initial levels of CBZ from CSEDD was 8.023 mcg/ml thereafter the levels were consistently high till 8 h and the initial levels of CBZ from plain solution was 3.62 mcg/ml followed by a gradual decline till 4 h evidently showing that the clearance of CBZ from CSEDD was reduced. The brain targeting index of CSEDD and solution were 3 and 2 respectively. The brain enhancement factor value was found to be 22.29 at 15 min revealing a very rapid penetration of CBZ into brain.

Conclusions: This study proposes intravenous CSEDD as a new brain delivery system and highlights two requirements to design adequate delivery systems for long circulating properties of the carrier and appropriate surface characteristics to allow interactions with BBB endothelial cells.

Keywords: SNEDDS; Carbamazepine; Intravenous; Brain; Targeting

Citation: Kumar GP, Rambhau D, Apte SS (2017) Brain Targeting Potential of Intravenous Carbamazepine SNEDDS. J Mol Pharm Org Process Res 5: 137. Doi: 10.4172/2329-9053.1000137

Copyright: © 2017 Kumar GP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top